EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25
What is EGFR? Treatment Options Glossary
EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate
 

News

 
news-purple.jpg
Research Highlights
Research Highlights
EGFR PositiveSeptember 16, 2023
Members forum overview
Members forum overview
EGFR PositiveJanuary 18, 2023
Look behind the scenes at LCNUK
Look behind the scenes at LCNUK
EGFR PositiveAugust 7, 2022
BTOG (British Thoracic Oncology Group) Summer Meeting 2022
BTOG (British Thoracic Oncology Group) Summer Meeting 2022
EGFR PositiveAugust 7, 2022
A New Patient Alliance - ODLC
A New Patient Alliance - ODLC
EGFR PositiveAugust 7, 2022
EGFR Positive publication in Oncology and Therapy journal
EGFR Positive publication in Oncology and Therapy journal
EGFR PositiveMarch 26, 2021
UKLCC Covid Matters Report
UKLCC Covid Matters Report
EGFR PositiveOctober 31, 2020
Osimertinib approved for untreated EGFR mutation-positive NSCLC
Osimertinib approved for untreated EGFR mutation-positive NSCLC
EGFR PositiveOctober 14, 2020
Osimertinib approved for treating EGFR mutation positive NSCLC
Osimertinib approved for treating EGFR mutation positive NSCLC
EGFR PositiveOctober 14, 2020
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Guest UserJune 10, 2020
UKLCC Early Diagnosis Matters Report
UKLCC Early Diagnosis Matters Report
EGFR PositiveFebruary 4, 2020
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
EGFR PositiveNovember 25, 2019
EGFR Positive UK first meeting
EGFR Positive UK first meeting
Guest UserNovember 16, 2019
Newer

The latest news

News
Accessing Non-NICE-Approved Treatments: What You Need to Know
Jan 8, 2026
Accessing Non-NICE-Approved Treatments: What You Need to Know
Jan 8, 2026
Read More →
Jan 8, 2026
Travel Insurance and Lung Cancer
Dec 20, 2025
Travel Insurance and Lung Cancer
Dec 20, 2025
Read More →
Dec 20, 2025
Major Advances for our EGFR Community: Approvals in Scotland & England
Dec 20, 2025
Major Advances for our EGFR Community: Approvals in Scotland & England
Dec 20, 2025
Read More →
Dec 20, 2025
EGFR+ UK Does the Tour de 4
Dec 20, 2025
EGFR+ UK Does the Tour de 4
Dec 20, 2025
Read More →
Dec 20, 2025
Information on Counselling with EGFR+ UK
Dec 20, 2025
Information on Counselling with EGFR+ UK
Dec 20, 2025
Read More →
Dec 20, 2025
EGFR+ UK One-Day Conferences
Aug 21, 2025
EGFR+ UK One-Day Conferences
Aug 21, 2025
Read More →
Aug 21, 2025

EGFR+ UK are proud members of Lung Cancer Europe

 
 

NEW! Follow us on Bluesky πŸ¦‹

 
 
View fullsize Our next Coffee and Chat is this Thursday 29 January at 10am β˜•

Coffee and Chat is a monthly online meet up for people impacted by an EGFR+ lung cancer diagnosis. It’s a gentle, relaxed space to connect with others who understand.

Maria loves
View fullsize
View fullsize We’re delighted so many of you could come and share the day with us in London today.

We’re sure you’ll agree Dr Alex Georgiou and Jo Vick were excellent. Both of these sessions were very strong, and there was plenty of time for que
View fullsize Today we’re joined by Jo Vick, Lead Lung Cancer Clinical Nurse Specialist at The Royal Marsden.

Jo has worked in lung cancer care for over 13 years and leads the CNS team at the Marsden. She’ll be sharing how the role has evolved alongsi

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.


Β© 2026 EGFR POSITIVE UK - Charity nΒΊ 1189722


PRIVACY POLICY

COOKIE POLICY